LAS VEGAS, Nov. 10, 2017 -- Chronic wounds are hard-to-heal wounds that proceed through the repair process without exhibiting a sustained and functional result. Complications of chronic wounds include different infections such as infective venous eczema, cellulitis, gangrene, lower-extremity amputations, and hemorrhage. Chronic wounds significantly impact the health and the quality of life of the patients and their families due to the low base rate of complete healing. They can lead to pain, loss of mobility and function, distress and anxiety, depression, social isolation and embarrassment, prolonged hospital stays leading to financial burden and even death. According to California Podiatric Medical Association (CPMA), 15% of people diagnosed with diabetes tend to develop a foot ulcer and 14 to 24% patients affected by foot ulcers will require amputation during their lifetime. Pressure ulcers and diabetic foot ulcers are long-lasting wounds instigated by elevated pressure and reduced angiogenic response i.e., less formation of new blood cells. Diabetic foot ulcers are categorized by redness, unusual swelling and odor from feet that are a few early symptoms.
A few of the key factors propelling the growth of Wound Closure Market are the increase in demand for less invasive procedures, predominance of chronic diseases across the world, and enhanced technology in wound care products. As per NCBI, pressure ulcers happen in 30 to 85% of patients suffering from spinal cord injuries, within the first month of injury. Development of cost effective products directed towards particular wounds will lead this market further. Therefore, cost efficiency and enhanced technology coupled with odor and pain control are a few prime factors which will rule the evolution of wound closure market in the coming years.
Get sample of this report: http://www.crystalmarketresearch.com/report-sample/HC06136
Moreover, increasing aging population vulnerable to chronic diseases such as diabetes leading to the heightened risk of chronic wounds will further contribute to the market growth. The global share of older people increased from 9.2% in 1990 to 11.7% in 2013 and will reach 21.1% by 2050 (Source: United Nations Department of Economic and Social Affairs). Further, it states that the number of older people is projected to reach 2 billion in 2050 from 841 million people in 2013. However, high cost of wound closure products and technical assistance for using these products will hamper the market growth.
Increased focus of key players on the development of innovative wound closure products to meet the unmet medical needs will further propel the market growth. For instance, in March 2017, Izun Pharmaceuticals Corporation obtained FDA approval for Curasite Wound Care Hydrogel for the treatment of leg ulcers and diabetic foot ulcers.
Major players
- Smith & Nephew PLC
- B. Braun Melsungen AG
- 3M Company
- Baxter International Inc.
- DeRoyalIndustries Inc.
- Johnson & Johnson Services Inc.
- Medtronic plc
- CryoLife Inc.
- Derma Sciences Inc. (acquired by Integra LifeSciences Holdings Corporation)
- BSN medical GmbH (acquired by SVENSKA CELLULOSA AKTIEBOLAGET SCA (publ))
Buy Report: http://www.crystalmarketresearch.com/checkout/HC06136
Key Findings of the Research Study:
- Increase in cases of road accidents and traumatic injuries are expected to largely contribute to the growth of wound closure market in coming years.
- With development of advanced wound closure products that effectively reduce the time to heal the wounds, the adoption of wound closure products is set to increase considerably during the forecast period.
- North America dominated the global wound closure market in 2016 due to increasing incidence of lifestyle disorders such as diabetes and growing geriatric population in the region.
- Asia-Pacific wound closure market is projected to witness significant growth during the forecast period owing to high prevalence of unmet medical needs in the region, increasing disposable income and efforts to improve healthcare infrastructure in developing countries such as China and India.
About Crystal Market Research
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact:
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: + 1-888-213-4282
Email: [email protected]
Website: http://www.crystalmarketresearch.com


Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 



